Search Results

There are 4934 results for: content related to: Use of Lipid Lowering Agents in the Prevention of Cardiovascular Disease

  1. Statins can modulate effectiveness of antitumor therapeutic modalities

    Medicinal Research Reviews

    Volume 30, Issue 1, January 2010, Pages: 102–135, Marek Jakobisiak and Jakub Golab

    Version of Record online : 12 JUN 2009, DOI: 10.1002/med.20162

  2. Atherosclerosis I: LDL Cholesterol Lowering

    Standard Article

    Burger's Medicinal Chemistry and Drug Discovery

    Duane A. Burnett and Harry R. Davis

    Published Online : 15 SEP 2010, DOI: 10.1002/0471266949.bmc185

  3. Analysis of five HMG-CoA reductase inhibitors— atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies

    Biomedical Chromatography

    Volume 20, Issue 3, March 2006, Pages: 282–293, Md. Khalid Pasha, Syed Muzeeb, Shaik Jafar Sadik Basha, Dhanya Shashikumar, Ramesh Mullangi and Nuggehally R. Srinivas

    Version of Record online : 5 SEP 2005, DOI: 10.1002/bmc.561

  4. Rho/ROCK pathway as a target of tumor therapy

    Journal of Neuroscience Research

    Volume 83, Issue 2, 1 February 2006, Pages: 243–255, R. Rattan, S. Giri, A.K. Singh and I. Singh

    Version of Record online : 29 DEC 2005, DOI: 10.1002/jnr.20707

  5. Physiological, morphological and kinetic aspects of lovastatin biosynthesis by Aspergillus terreus

    Biotechnology Journal

    Volume 4, Issue 5, May 2009, Pages: 647–664, Marcin Bizukojc and Stanislaw Ledakowicz

    Version of Record online : 18 MAY 2009, DOI: 10.1002/biot.200800289

  6. You have free access to this content
    Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism

    International Journal of Cancer

    Volume 100, Issue 1, 1 July 2002, Pages: 111–118, Wojciech Feleszko, Izabela Młynarczuk, Dominika Olszewska, Ahmad Jalili, Tomasz Grzela, Witold Lasek, Grażyna Hoser, Grażyna Korczak-Kowalska and Marek Jakóbisiak

    Version of Record online : 6 MAY 2002, DOI: 10.1002/ijc.10440

  7. Lovastatin and (+)-geodin formation by Aspergillus terreus ATCC 20542 in a batch culture with the simultaneous use of lactose and glycerol as carbon sources

    Engineering in Life Sciences

    Volume 11, Issue 3, June 2011, Pages: 272–282, Marcin Bizukojc and Marta Pecyna

    Version of Record online : 10 JUN 2011, DOI: 10.1002/elsc.201000179

  8. You have free access to this content
    A comparison of the effects of simvastatin and pravastatin monotherapy on muscle histology and permeability in hypercholesterolaemic patients.

    British Journal of Clinical Pharmacology

    Volume 39, Issue 2, February 1995, Pages: 135–141, J Contermans, JW Smit, PR Bar and DW Erkelens

    Version of Record online : 4 JUL 2012, DOI: 10.1111/j.1365-2125.1995.tb04420.x

  9. Lovastatin and (+)-geodin production by Aspergillus terreus from crude glycerol

    Engineering in Life Sciences

    Volume 15, Issue 2, March 2015, Pages: 220–228, Muhamad Hafiz Abd Rahim, Hanan Hasan, Alejandro Montoya and Ali Abbas

    Version of Record online : 14 FEB 2015, DOI: 10.1002/elsc.201400140

  10. You have free access to this content
    Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience

    Journal of Clinical Pharmacy and Therapeutics

    Volume 24, Issue 6, December 1999, Pages: 397–408, A. Jardine and H. Holdaas

    Version of Record online : 22 AUG 2003, DOI: 10.1046/j.1365-2710.1999.00252.x

  11. You have free access to this content
    The pharmacology of fluvastatin, a new HMG-CoA reductase inhibitor

    Clinical Cardiology

    Volume 17, Issue S4, December 1994, Pages: IV-3–IV-10, William R. Garnett

    Version of Record online : 7 AUG 2009, DOI: 10.1002/clc.4960171603

  12. You have free access to this content
    Clinical practice guidelines for managing dyslipidemias in kidney transplant patients: a report from the Managing Dyslipidemias in Chronic Kidney Disease Work Group of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative

    American Journal of Transplantation

    Volume 4, Issue s7, March 2004, Pages: 13–53, B. Kasiske, F.G. Cosio, J. Beto, K. Bolton, B.M. Chavers, R. Grimm Jr., A. Levin, B. Masri, R. Parekh, C. Wanner, D.C. Wheeler and P.W.F. Wilson

    Version of Record online : 15 MAR 2004, DOI: 10.1111/j.1600-6135.2004.0355.x

  13. You have free access to this content
    A systematic review and meta-analysis on the therapeutic equivalence of statins

    Journal of Clinical Pharmacy and Therapeutics

    Volume 35, Issue 2, April 2010, Pages: 139–151, T.-C. Weng, Y.-H. Kao Yang, S.-J. Lin and S.-H. Tai

    Version of Record online : 14 AUG 2009, DOI: 10.1111/j.1365-2710.2009.01085.x

  14. Rhabdomyolysis and Satin Therapy: Relevance to the Elderly

    The American Journal of Geriatric Cardiology

    Volume 11, Issue 1, Jan/Feb 2002, Pages: 48–55, Domenic A. Sica and 1,2 Todd W.B. Gehr 2

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1076-7460.2002.01422.x

  15. You have free access to this content
    HMG CoA reductase inhibitors (statins) for kidney transplant recipients

    Intervention Review

    The Cochrane Library

    Suetonia C Palmer, Sankar D Navaneethan, Jonathan C Craig, Vlado Perkovic, David W Johnson, Sagar U Nigwekar, Jorgen Hegbrant and Giovanni FM Strippoli

    Published Online : 28 JAN 2014, DOI: 10.1002/14651858.CD005019.pub4

  16. You have free access to this content
    Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice

    International Journal of Cancer

    Volume 97, Issue 6, 20 February 2002, Pages: 746–750, Adam Giermasz, Marcin Makowski, Ewa Kozłowska, Dominika Nowis, Małgorzata Maj, Ahmad Jalili, Wojciech Feleszko, Cezary Wójcik, Anna Dąbrowska, Marek Jakóbisiak and Jakub Gołąb

    Version of Record online : 29 NOV 2001, DOI: 10.1002/ijc.10119

  17. You have free access to this content
    Heterozygous familial hypercholesterolaemia is associated with pathological exercise-induced leakage of muscle proteins, which is not aggravated by simvastatin therapy

    European Journal of Clinical Investigation

    Volume 25, Issue 2, February 1995, Pages: 79–84, J. W. A. SMIT, P. R. BÄR, R. A. GEERDINK† and D. W. ERKELENS

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1365-2362.1995.tb01530.x

  18. Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance

    Clinical Pharmacology & Therapeutics

    Volume 80, Issue 6, December 2006, Pages: 565–581, Pertti J. Neuvonen, Mikko Niemi and Janne T. Backman

    Version of Record online : 15 DEC 2006, DOI: 10.1016/j.clpt.2006.09.003

  19. Lovastatin and Other HMG-CoA Reductase Inhibitors

    The Journal of Clinical Pharmacology

    Volume 29, Issue 11, November 1989, Pages: 975–982, William H. Frishman, Peter Zimetbaum and Jeremy Nadelmann

    Version of Record online : 8 MAR 2013, DOI: 10.1002/j.1552-4604.1989.tb03264.x

  20. Statins in dermatology

    International Journal of Dermatology

    Volume 49, Issue 11, November 2010, Pages: 1235–1243, Farideh Jowkar and Mohammad Reza Namazi

    Version of Record online : 22 OCT 2010, DOI: 10.1111/j.1365-4632.2010.04579.x